4//SEC Filing
ACELRX PHARMACEUTICALS INC 4
Accession 0001437749-17-002063
$TLPHCIK 0001427925operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 8:54 PM ET
Size
5.4 KB
Accession
0001437749-17-002063
Insider Transaction Report
Form 4
Mitchell Jane Wright
Chief Legal Officer
Transactions
- Award
Common Stock (Right to Buy)
2017-02-07+79,500→ 79,500 totalExercise: $3.00From: 2018-02-07Exp: 2028-02-06→ Common Stock (79,500 underlying)
Footnotes (3)
- [F1]Issued pursuant to the 2011 Equity Incentive Plan.
- [F2]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
- [F3]100% Acceleration upon Change of Control.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001427925
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 8:54 PM ET
- Size
- 5.4 KB